drugset / Trial / NCT00693472
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to evaluate the effectiveness of preladenant in the prevention (Part 1) or treatment (Part 2) of antipsychotic induced akathisia in participants with acute psychosis using the Barnes Akathisia Scale.
Timeline
- Start
- 2007-08-15
- Primary completion
- 2008-12-12
- Completion
- 2009-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Preladenant | Small molecule | 25 mg | Oral |
| Background | Haloperidol | Other / unclassified | 7.5 mg | Oral |
| Background | Propranolol | Small molecule | — | — |